Screen Reader Mode Icon

Organized by Clarivate in association with Pharmexcil

This survey aims to evaluate the Indian Pharma industry’s perspective considering the global pandemic.

Question Title

* 1. Please enter your complete name.

Question Title

* 2. Please enter your email address.

Question Title

* 3. Please enter your designation.

Question Title

* 4. Please enter your company name.

Question Title

* 5. Company type

Question Title

* 6. Company turnover

Question Title

* 7. Market focus

Question Title

* 8. Therapy focus (check all that apply)

Question Title

* 9. What is your current degree of dependency on imported APIs /key starting materials?

Question Title

* 10. Which of the following countries contributes to your imports of raw materials and APIs? (check all that apply)

Question Title

* 11. Considering the current import restrictions do you foresee changes in your sourcing pattern?

Question Title

* 12. Do you plan to add to your portfolio the products that were previously discontinued on account of foreign companies offering them at lower price margins?

Question Title

* 13. Will there be new anti-viral products added in the product portfolio?

Question Title

* 14. Are you adding new non-antiviral products to your portfolio?

Question Title

* 15. Do you have the infrastructure for large scale manufacturing of anti-viral drugs?

Question Title

* 16. Are you willing to collaborate with MNCs to manufacture anti-viral drugs?

Question Title

* 17. Do you intend to add any of the identified 53 APIs/KSMs in your product portfolio to leverage production subsidy?

0 of 24 answered
 

T